BioBusiness Asia Conference 2007
This conference is intended to encourage a wide range of participants to discuss the approaches in integrating biotechnology innovation with business opportunities in an attempt to nurture emerging enterprises and establish a thriving biotech industry.
The BioBusiness Asia Conference, serving as a communication platform, has attracted more than 1,500 participants from around the world to exchange perspectives on biotechnology industry over the past five years. International sponsors from a variety of sectors are highly supportive, including MDS Capital Corp., Burrill & Company, MPM Capital, BioAsia Investment, Jerusalem Global Ventures, etc. Each year a number of qualified emerging biotech companies are selected to present their business models and plans, giving them an opportunity to demonstrate business portfolios.
Under the theme of “From Biotech Innovation to Business Boost: A Global Perspective,” this conference is intended to encourage a wide range of participants to discuss the approaches in integrating biotechnology innovation with business opportunities in an attempt to nurture emerging enterprises and establish a thriving biotech industry. The focused topic of this year’s Conference involves the global trend of preventive, predictive, and personalized health care by introducing state-of-the-art biotechnology and discovering the partnership between East and West.
The 2007 Symposium on Chronic Hepatitis and Liver Diseases is held in conjunction with this year’s Conference.
Secretariat Office of BioBusinessAsia Conference
Biomedical Engineering Research Laboratories, Industrial Technology Research Institute
236R, 53 B, 195 Sec. 4, Chung Hsing Rd., Chutung, Hsinchu, Taiwan 310, R.O.C.
Tel: +886-3-591 2142
Fax: +886-3-591 0170
Email. [email protected]
